No association between dorsolateral prefrontal gray matter deficit and N-acetyl aspartate ratios in schizophrenia

Neuropsychobiology

Volumn 54, Issue 3, 2007, Pages 171-178

  Molina, Vicente ^a   Sanz, Javier ^b   Sarramea, Fernando ^d   Luque, Rogelio ^d   Benito, Carlos ^c   Palomo, Tomás ^b  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c Montepríncipe University Hospital   (Spain)

^d HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Cortical deficit; N acetyl aspartate; Prefrontal gray matter; Schizophrenia

Indexed keywords

N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BRAIN TISSUE; CALCULATION; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAY MATTER; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; ASPARTIC ACID; CEREBROSPINAL FLUID; EXTRACELLULAR FLUID; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NEURONS; ORGAN SIZE; PREFRONTAL CORTEX; SCHIZOPHRENIA; STATISTICS, NONPARAMETRIC;

EID: 33847747810     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000098653     Document Type: Article

References (46)

1. Urenjak J, Williams SR, Gadian DG, Noble M: Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 1993;13:981-989.
2. Stanley JA, Pettegrew JW, Keshavan M: Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings. Part I. Biol Psychiatry 2000;48:357-368.
3. Bhakoo KK, Pearce D: In vitro expression of N-acetyl aspartate by oligodendrocytes: implications for proton magnetic resonance spectroscopy signal in vivo. J Neurochem 2000;74:254-262.
4. 1H NMR spectroscopy. NMR Biomed 2002;15:375-384.
5. 1H-MR spectroscopy and gray matter volume of the anterior cingulate cortex in schizophrenia. Neuroreport 2002;13:2133-2137.
6. Lim KO, Adalsteinsson E, Spielman D, Sullivan EV, Rosenbloom MJ, Pfefferbaum A: Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia. Arch Gen Psychiatry 1998;55:346-352.
7. 1H-MRS and tissue segmentation. Schizophr Res 2001;52:87-99.
8. Shenton ME, Dickey CC, Frumin M, McCarley RW: A review of MRI findings in schizophrenia. Schizophr Res 2001;49:1-52.
9. Molina V, Sanz J, Sarramea F, Benito C, Palomo T: Lower prefrontal gray matter volume in schizophrenia in chronic but not in first episode schizophrenia patients. Psychiatry Res 2004;131:45-56.
10. Molina V, Reig S, Sanz J, Palomo T, Benito C, Sánchez J, Sarramea F, Pascau J, Desco M: Increase in gray matter volume and decrease in white matter volume in the cerebral cortex during treatment with atypical neuroleptics in schizophrenia. Schizophr Res 2005;80:61-71.
11. Molina V, Reig S, Sánchez J, Sanz J, Benito C, Pascau J, Marta CS, Sarramea F, Gispert JD, Misiego JM, Palomo T, Desco M: N-acetyl aspartate in the dorsolateral prefrontal region in the early years of schizophrenia are inversely related to illness duration. Schizophr Res 2005:209-219.
12. Hollingshead A, Frederick R: Social stratification and psychiatric disorders. Am Soc Rev 1953;18:163-189.
13. Bottomley PA: Spatial localization in NMR spectroscopy in vivo. Ann NY Acad Sci 1987;508:333-348.
14. 1H magnetic resonance spectra; in McWhiter JG (ed): Mathematics in Processing III. Oxford, Clarendon Press, 1994, pp 175-195.
15. Vanhamme L, van den Boogaart A, Van Huffel S Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 1997;129:35-43.
16. Kates WR, Warsofsky IS, Patwardhan A, Abrams MT, Liu AM, Naidu S, Kaufmann WE, Reiss AL: Automated Talairach atlas-based parcellation and measurement of cerebral lobes in children. Psychiatry Res 1999;91:11-30.
17. Andreasen NC, Rajarethinam R, Cizadlo T, Arndt S, Swayze VW 2nd,, Flashman LA, O'Leary DS, Ehrhardt JC, Yuh WT: Automatic atlas-based volume estimation of human brain regions from MR images. J Comput Assist Tomogr 1996;20: 98-106.
18. Desco M, Pascau J, Reig S, Gispert JD, Santos A, Benito B, Molina V, Garcia-Barreno P: Multimodality image quantification using Talairach grid. Proc SPIE Med Imaging 2001;4422:1385-1392.
19. Talairach J, Tournoux P: Co-Planar Stereotaxic Atlas of the Human Brain. New York, Thieme Medical, 1988.
20. Ashburner J, Friston KJ: Multimodal image coregistration and partitioning - a unified framework. Neuroimage 1997;6:209-217.
21. Ashburner J, Friston KJ: Voxel-based morphometry - the methods. Neuroimage 2000;11:805-821.
22. Chard DT, Parker GJ, Griffin CM, Thompson AJ, Miller DH: The reproducibility and sensitivity of brain tissue volume measurements derived from an SPM-based segmentation methodology. J Magn Reson Imaging 2002;15:259-267.
23. Gispert JD, Reig S, Pascau J, Vaquero JJ, Desco M: Repeatability of brain tissue volume quantification using magnetic resonance images. 10th Annu Meet Organ Human Brain Mapp, Budapest, 2004. Neuroimage 2004;22(suppl 1):S45.
24. Molina V, Reig S, Sarramea F, Sanz JF, Artaloytia J, Luque R, Aragüés M, Pascau J, Benito C, Palomo T, Desco M: Anatomical and functional brain variables associated to clozapine response in treatment-resistant schizophrenia. Psychiatry Res 2003;124:153-161.
25. Pfefferbaum A, Lim KO, Zipursky RB, Mathalon DH, Rosenbloom MJ, Lane B, Ha CN, Sullivan EV: Brain gray and white matter volume loss accelerates with aging in chronic alcoholics: a quantitative MRI study. Alcohol Clin Exp Res 1992;16:1078-1089.
26. Woods BT: Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism. Am J Psychiatry 1998;155:1661-1670.
27. Gur RE, Cowell P, Turetsky BI, Gallacher F, Cannon T, Bilker W, Gur RC: A follow-up magnetic resonance imaging study of schizophrenia: relationship of neuroanatomical changes to clinical and neurobehavioral measures. Arch Gen Psychiatry 1998;55:145-52.
28. Selemon LD, Goldman-Rakic PS: The reduced neuropil hypothesis: a circuit based model of schizophrenia Biol Psychiatry 1999;45:17-25.
29. Thune JJ, Uylings HB, Pakkenberg B: No deficit in total number of neurons in the prefrontal cortex in schizophrenics. J Psychiatr Res 2001;35:15-21.
30. McGlashan TH, Hoffman RE: Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Arch Gen Psychiatry 2000;57:637-648.
31. Stark AK, Uylings HB, Sanz-Arigita E, Pakkenberg B: Glial cell loss in the anterior cingulate cortex, a subregion of the prefrontal cortex, in subjects with schizophrenia. Am J Psychiatry 2004;161:882-888.
32. Rajkowska G, Miguel-Hidalgo JJ, Makkos Z, Meltzer H, Overholser J, Stockmeier C: Layer-specific reductions in GFAP-reactive astroglia in the dorsolateral prefrontal cortex in schizophrenia. Schizophr Res 2002;57:127-138.
33. Miller RF: D-Serine as a glial modulator of nerve cells. Glia 2004;47:275-283.
34. Garver DL, Holcomb JA, Christensen JD: Cerebral cortical gray expansion associated with two second-generation antipsychotics. Biol Psychiatry 2005;58:62-6.
35. Keshavan MS, Haas GL, Kahn CE, Aguilar E, Dick EL, Schooler NR, Sweeney JA, Pettegrew JW: Superior temporal gyrus and the course of early schizophrenia: progressive, static, or reversible? J Psychiatr Res 1998;32:161-167.
36. Selemon LD, Lidow MS, Goldman-Rakic PS: Increased volume and glial density in primate prefrontal cortex associated with chronic antipsychotic drug exposure. Biol Psychiatry 1999;46:161-172.
37. Keshavan MS, Stanley JA, Pettegrew JW: Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings. Part II. Biol Psychiatry 2000;48:369-380.
38. Glantz LA, Lewis DA: Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry 2000;57:65-73.
39. Ende G, Braus DF, Walter S, Weber-Fahr W, Soher B, Maudsley AA, Henn FA: Effects of age, medication, and illness duration on the N-acetyl aspartate signal of the anterior cingulate region in schizophrenia. Schizophr Res 2000;41:389-395.
40. Bertolino A, Nawroz S, Mattay VS, Barnett AS, Duyn JH, Moonen CT, Frank JA, Tedeschi G, Weinberger DR: Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am J Psychiatry 1996;153:1554-1563.
41. 1H-magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: clinical, neurodevelopmental, and cognitive correlates. Biol Psychiatry 1994;36:792-800.
42. Deicken RF, Zhou L, Corwin F, Vinogradov S, Weiner MW: Decreased left frontal lobe N-acetylaspartate in schizophrenia. Am J Psychiatry 1997;154:688-690.
43. Deicken RF, Zhou L, Schuff N, Weiner MW: Proton magnetic resonance spectroscopy of the anterior cingulate region in schizophrenia. Schizophr Res 1997;27:65-71.
44. Delamillieure P, Constans JM, Fernández J, Brazo P, Benali K, Courthéoux P, Thibaut F, Petit M, Dollfus S: Proton magnetic resonance spectroscopy in schizophrenia: investigation of the right and left hippocampus, thalamus and prefrontal cortex. Schizophr Bull 2002;28:329-339.
45. Andersen BB, Pakkenberg B: Stereological quantitation in cerebella from people with schizophrenia. Br J Psychiatry 2003;182:354-361.
46. Danos P, Baumann B, Bernstein HG, Stauch R, Krell D, Falkai P, Bogerts B: The ventral lateral posterior nucleus of the thalamus in schizophrenia: a post-mortem study. Psychiatry Res 2002;114:1-9.